Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +64.4% | +41840.2% | 3 / 3 | +16.0% | +1.66 pp | +4.24 pp | +37.7% | 0.00 | 7.18 | 193 | +16,0% | 27,8 | +64,4% | 7.18 | 7.01 | +2,4% |
| Pts | 12 | 12 | 12 | 8 | 8 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 40.200 (close price on 2026-10-19)EPS (TTM): 5.602
Financial charts
1.Revenue & growth
VND bn193Q2/26
1.Revenue & growth
VND bn193Q2/26
2.Profit & growth
VND bn27,8Q2/26
3.Profit mix (Penman)
VND bn101Q2/26
4.Margins & cost structure
%21.8%Q2/26
5.Returns & cash cycle
% · days58.9%Q2/26
6.Earnings quality & cash
VND bn138Q2/26
7.Asset structure
VND bn293Q2/26
8.Funding & debt health
VND bn · times293Q2/26
9.Revenue backlog
VND bn2,73Q2/26
10.Valuation
times · %7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.819Q2/26
Adjusted EPS growth, latest quarter
64.4%
Average adjusted EPS growth, 3 quarters
66.4%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26